Antipsychotics and glucose metabolism: how brain and body collide

Insulin signalling and the regulation of glucose and lipid metabolism

Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326 · see citing works

Consensus development conference on antipsychotic drugs and obesity and diabetes

American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554 · see citing works

Hypothalamic insulin signaling is required for inhibition of glucose production

Obici, S., Zhang, B. B., Karkanias, G., & Rossetti, L. (2002) · Nature Medicine · doi:10.1038/nm1202-798 · Cited by 904 · see citing works

The unhealthy lifestyle of people with schizophrenia

Brown, S., Birtwistle, J., ROE, L., & THOMPSON, C. (1999) · Psychological Medicine · doi:10.1017/s0033291798008186 · Cited by 877 · see citing works

Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year Studies

Correll, C. U., Leucht, S., & Kane, J. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.414 · Cited by 709 · see citing works

National Trends in the Outpatient Treatment of Children and Adolescents With Antipsychotic Drugs

Olfson, M., Blanco, C., Liu, L., Moreno, C., & Laje, G. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.6.679 · Cited by 590 · see citing works

Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy

Kapur, S., VanderSpek, S. C., Brownlee, B. A., & Nóbrega, J. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.046987 · Cited by 480 · see citing works

Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis

Crane, J., Palanivel, R., Mottillo, E., Bujak, A. L., Wang, H.-Q., Ford, R., Collins, A., Blümer, R., Fullerton, M., Yabut, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3766 · Cited by 462 · see citing works

Intracellular Serotonin Modulates Insulin Secretion from Pancreatic β-Cells by Protein Serotonylation

Paulmann, N., Grohmann, M., Voigt, J.-P., Bert, B., Vowinckel, J., Bader, M., Skelin, M., Jevšek, M., Fink, H., Rupnik, M., et al. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000229 · Cited by 404 · see citing works

Antipsychotic drug-induced weight gain mediated by histamine H 1 receptor-linked activation of hypothalamic AMP-kinase

Kim, S. F., Huang, A. S., Snowman, A. M., Teuscher, C., & Snyder, S. H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611417104 · Cited by 394 · see citing works

Second-Generation Antipsychotics and Extrapyramidal Adverse Effects

Divac, N., Prostran, M. S., Jakovčevski, I., & Cerovac, N. (2014) · BioMed Research International · doi:10.1155/2014/656370 · Cited by 328 · see citing works

Glucose Metabolism in Patients With Schizophrenia Treated With Atypical Antipsychotic Agents

Henderson, D. C., Cagliero, E., Copeland, P. M., Borba, C. P. C., Evins, A. E., Hayden, D. L., Weber, M., Anderson, E. J., Allison, D. B., Daley, T. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.1.19 · Cited by 317 · see citing works

Cooperation between brain and islet in glucose homeostasis and diabetes

Schwartz, M. W., Seeley, R. J., Tschöp, M. H., Woods, S. C., Morton, G. J., Myers, M. G., & D’Alessio, D. A. (2013) · Nature · doi:10.1038/nature12709 · Cited by 311 · see citing works

Arcuate NPY Controls Sympathetic Output and BAT Function via a Relay of Tyrosine Hydroxylase Neurons in the PVN

Shi, Y.-C., Lau, J., Lin, Z., Zhang, H., Zhai, L., Sperk, G., Heilbronn, R., Mietzsch, M., Weger, S., Huang, X.-F., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.01.006 · Cited by 266 · see citing works

Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion

Rubı́, B., Ljubicic, S., Pournourmohammadi, S., Carobbio, S., Armanet, M., Bartley, C., & Maechler, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505560200 · Cited by 257 · see citing works

Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes

DeFronzo, R. A. (2011) · Diabetes Care · doi:10.2337/dc11-0064 · Cited by 257 · see citing works

Acute Effects of Atypical Antipsychotics on Whole-Body Insulin Resistance in Rats: Implications for Adverse Metabolic Effects

Houseknecht, K. L., Robertson, A. S., Zavadoski, W. J., Gibbs, E. M., Johnson, D. E., & Rollema, H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301209 · Cited by 239 · see citing works

Serotonin 2C Receptor Agonists Improve Type 2 Diabetes via Melanocortin-4 Receptor Signaling Pathways

Zhou, L., Sutton, G. M., Rochford, J. J., Semple, R. K., Lam, D. D., Oksanen, L., Thornton-Jones, Z. D., Clifton, P. G., Yueh, C.-Y., Evans, M. L., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.008 · Cited by 213 · see citing works

Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease

Teff, K. L., Rickels, M. R., Grudziak, J., Fuller, C., Nguyen, H.-L., & Rickels, K. (2013) · Diabetes · doi:10.2337/db13-0430 · Cited by 195 · see citing works

Insulin and Insulin-Like Growth Factor-1 Abnormalities in Antipsychotic-Naive Schizophrenia

Venkatasubramanian, G., Chittiprol, S., Neelakantachar, N., Naveen, M. N., Thirthall, J., Gangadhar, B. N., & Shetty, K. T. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07020233 · Cited by 191 · see citing works

Diabetes mellitus and schizophrenia: Historical perspective

Kohen, D. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.184.47.s64 · Cited by 181 · see citing works

Compendium of Pharmaceuticals and Specialties

Hartleib, C. J. (1974) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/31.11.1085a · Cited by 170 · see citing works

Metabolic Dysregulation With Atypical Antipsychotics Occurs in the Absence of Underlying Disease A Placebo-Controlled Study of Olanzapine and Risperidone in Dogs

Ader, M., Kim, S. P., Catalano, K. J., Ionut, V., Hücking, K., Richey, J. M., Kabir, M., & Bergman, R. N. (2005) · Diabetes · doi:10.2337/diabetes.54.3.862 · Cited by 166 · see citing works

Insulin Resistance and Increased Leptin Concentrations in Noncompliant Schizophrenia Patients but Not in Antipsychotic-Naive First-Episode Schizophrenia Patients

Arranz, B., Rosel, P., Ramírez, N. D., Dueñas, R., Fernández, P., Sanchez, J. M., Navarro, M. A., & San, L. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1007 · Cited by 161 · see citing works

Roles of Insulin Receptor Substrate-1, Phosphatidylinositol 3-Kinase, and Release of Intracellular Ca2+ Stores in Insulin-stimulated Insulin Secretion in β-Cells

Aspinwall, C. A., Qian, W., Roper, M. G., Kulkarni, R., Kahn, C. R., & Kennedy, R. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909647199 · Cited by 160 · see citing works

Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats

Lecklin, A., Etu-Seppälä, P., Stark, H., & Tuomisto, L. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00186-3 · Cited by 156 · see citing works

Atypical Antipsychotic Drugs Directly Impair Insulin Action in Adipocytes: Effects on Glucose Transport, Lipogenesis, and Antilipolysis

Vestri, H. S., Maianu, L., Moellering, D. R., & Garvey, W. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301142 · Cited by 153 · see citing works

Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance

García-Tornadú, I., Ornstein, A. M., Chamson-Reig, A., Wheeler, M. B., Hill, D. J., Arany, E. J., Rubinstein, M., & Becú‐Villalobos, D. (2010) · Endocrinology · doi:10.1210/en.2009-0996 · Cited by 147 · see citing works

Atypical Antipsychotics and Glucose Homeostasis

Bergman, R. N., & Ader, M. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0414 · Cited by 137 · see citing works

Endogenous and Antipsychotic-Related Risks for Diabetes Mellitus in Young People With Schizophrenia: A Danish Population-Based Cohort Study

Rajkumar, A. P., Horsdal, H. T., Wimberley, T., Cohen, D., Mors, O., Børglum, A. D., & Gasse, C. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.16040442 · Cited by 137 · see citing works

Inhibitory Effects of Antipsychotics on Carbachol-Enhanced Insulin Secretion From Perifused Rat Islets

Johnson, D. E., Yamazaki, H., Ward, K. M., Schmidt, A. W., Lebel, W. S., Treadway, J. L., Gibbs, E. M., Zawalich, W. S., & Rollema, H. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1552 · Cited by 131 · see citing works

Hyperglycemic Clamp Assessment of Insulin Secretory Responses in Normal Subjects Treated with Olanzapine, Risperidone, or Placebo

Sowell, M. O., Mukhopadhyay, N. D., Cavazzoni, P. A., Shankar, S. S., Steinberg, H. O., Breier, A. F., Beasley, C. M., & Dananberg, J. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.6.8599 · Cited by 129 · see citing works

Serotonin (5-Hydroxytryptamine), a Novel Regulator of Glucose Transport in Rat Skeletal Muscle

Hajduch, É., Rencurel, F., Balendran, A., Batty, I. H., Downes, C. P., & Hundal, H. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13563 · Cited by 127 · see citing works

Intracerebroventricular Administration of Neuropeptide Y Induces Hepatic Insulin Resistance via Sympathetic Innervation

van den Hoek, A. M., Heijningen, C. L. V., der Elst, J. P. S.-V., Ouwens, D. M., Havekes, L. M., Romijn, J. A., Kalsbeek, A., & Pijl, H. (2008) · Diabetes · doi:10.2337/db07-1658 · Cited by 127 · see citing works

A Double Blind, Placebo-Controlled, Randomized Crossover Study of the Acute Metabolic Effects of Olanzapine in Healthy Volunteers

Albaugh, V. L., Singareddy, R. K., Mauger, D., & Lynch, C. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022662 · Cited by 119 · see citing works

Insulin resistance and secretion in vivo: Effects of different antipsychotics in an animal model

Chintoh, A. F., Mann, S. W., Lam, L., Giacca, A., Fletcher, P. J., Nóbrega, J. N., & Remington, G. J. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.12.012 · Cited by 117 · see citing works

Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes

Lin, P., & Shuldiner, A. R. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.08.022 · Cited by 114 · see citing works

Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis

Albaugh, V. L., Judson, J., She, P., Lang, C. H., Maresca, K. P., Joyal, J. L., & Lynch, C. J. (2010) · Molecular Psychiatry · doi:10.1038/mp.2010.33 · Cited by 114 · see citing works

Inhibition of glucose transport in PC12 cells by the atypical antipsychotic drugs risperidone and clozapine, and structural analogs of clozapine

Ardizzone, T. D., Bradley, R. J., Freeman, A. M., & Dwyer, D. S. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03026-8 · Cited by 112 · see citing works

Second-Generation Antipsychotic Drugs, Olanzapine, Quetiapine, and Clozapine Enhance Neurite Outgrowth in PC12 Cells Via PI3K/AKT, ERK, and Pertussis Toxin-Sensitive Pathways

Lu, X., & Dwyer, D. S. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:27:1:043 · Cited by 112 · see citing works

Insulin Resistance and Adiponectin Levels in Drug-Free Patients with Schizophrenia: A Preliminary Report

Cohn, T. A., Remington, G. J., Zipursky, R. B., Azad, A., Connolly, P., & Wolever, T. M. S. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100608 · Cited by 109 · see citing works

Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?

Sengupta, S. M., Parrilla-Escobar, M. A., Klink, R., Fathalli, F., Ng, Y. K., Stip, É., Baptista, T., MALLA, A. K., & Joober, R. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.02.013 · Cited by 108 · see citing works

Intranasal Insulin Suppresses Endogenous Glucose Production in Humans Compared With Placebo in the Presence of Similar Venous Insulin Concentrations

Dash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · Diabetes · doi:10.2337/db14-0685 · Cited by 108 · see citing works

Preclinical models of antipsychotic drug-induced metabolic side effects

Boyda, H. N., Tse, L., Procyshyn, R. M., Honer, W. G., & Barr, A. M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.07.002 · Cited by 104 · see citing works

Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex

Roh, M., Seo, M. S., Kim, Y., Kim, S. H., Jeon, W. J., Ahn, Y. M., Kang, U. G., Juhnn, Y. S., & Kim, Y. S. (2007) · Experimental & Molecular Medicine · doi:10.1038/emm.2007.39 · Cited by 103 · see citing works

Insulin Resistance and Decreased Glucose-Stimulated Insulin Secretion After Acute Olanzapine Administration

Chintoh, A. F., Mann, S. W., Lam, L., Lam, C., Cohn, T. A., Fletcher, P. J., Nóbrega, J. N., Giacca, A., & Remington, G. J. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318184b4c5 · Cited by 96 · see citing works

Effects of Olanzapine and Ziprasidone on Glucose Tolerance in Healthy Volunteers

Sacher, J., Mossaheb, N., Spindelegger, C., Klein, N., Geiss-Granadia, T., Sauermann, R., Lackner, E., Joukhadar, C., Müller, M., & Kasper, S. F. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301541 · Cited by 95 · see citing works

Olanzapine impairs glycogen synthesis and insulin signaling in L6 skeletal muscle cells

Engl, J., Laimer, M. W., Niederwanger, A., Kranebitter, M., Starzinger, M., Pedrini, M. T., Fleischhacker, W. W., Patsch, J. R., & Ebenbichler, C. F. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001729 · Cited by 92 · see citing works

Central Nervous System Delivery of the Antipsychotic Olanzapine Induces Hepatic Insulin Resistance

Martins, P. J. F., Haas, M., & Obici, S. (2010) · Diabetes · doi:10.2337/db10-0449 · Cited by 91 · see citing works

Effects of Olanzapine and Haloperidol on the Metabolic Status of Healthy Men

Vidarsdóttir, S., van Weenen, J. E. D. L., Frölich, M., Roelfsema, F., Romijn, J. A., & Pijl, H. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1815 · Cited by 91 · see citing works

Involvement of Hypothalamic AMP-Activated Protein Kinase in Leptin-Induced Sympathetic Nerve Activation

Tanida, M., Yamamoto, N., Shibamoto, T., & Rahmouni, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056660 · Cited by 88 · see citing works

Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat

Smith, G. C., Chaussade, C., Vickers, M. H., Jensen, J., & Shepherd, P. R. (2008) · Diabetologia · doi:10.1007/s00125-008-1152-3 · Cited by 87 · see citing works

Olanzapine produces trophic effects in vitro and stimulates phosphorylation of Akt/PKB, ERK1/2, and the mitogen-activated protein kinase p38

Lu, X., Bradley, R. J., & Dwyer, D. S. (2004) · Brain Research · doi:10.1016/j.brainres.2004.03.018 · Cited by 87 · see citing works

Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats

He, M. X., Zhang, Q., Deng, C., Wang, H., Lian, J., & Huang, X. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.01.018 · Cited by 87 · see citing works

Hypothalamic AMP-Activated Protein Kinase Regulates Glucose Production

Yang, C. S., Lam, C. K. L., Chari, M., Cheung, G. W. C., Kokorovic, A., Gao, S., Leclerc, I., Rutter, G. A., & Lam, T. K. T. (2010) · Diabetes · doi:10.2337/db10-0221 · Cited by 86 · see citing works

Atypical Antipsychotics Rapidly and Inappropriately Switch Peripheral Fuel Utilization to Lipids, Impairing Metabolic Flexibility in Rodents

Albaugh, V. L., Vary, T. C., Ilkayeva, O., Wenner, B. R., Maresca, K. P., Joyal, J. L., Breazeale, S. D., Elich, T. D., Lang, C. H., & Lynch, C. J. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbq053 · Cited by 86 · see citing works

Isochroman-6-carboxamides as Highly Selective 5-HT1D Agonists: Potential New Treatment for Migraine without Cardiovascular Side Effects

Ennis, M. D., Ghazal, N. B., Hoffman, R. L., Smith, M., Schlachter, S. K., Lawson, C., Im, W. B., Pregenzer, J. F., Svensson, K. A., Lewis, R. A., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980137o · Cited by 84 · see citing works

Acute Effects of Single-Dose Olanzapine on Metabolic, Endocrine, and Inflammatory Markers in Healthy Controls

Hahn, M., Wolever, T., Arenovich, T., Teo, C., Giacca, A., Powell, V., Clarke, L., Fletcher, P. J., Cohn, T. A., McIntyre, R. S., et al. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829e8333 · Cited by 83 · see citing works

The dopamine receptor D2 agonist bromocriptine inhibits glucose-stimulated insulin secretion by direct activation of the α2-adrenergic receptors in beta cells

van Weenen, J. E. D. L., Parlevliet, E. T., Maechler, P., Havekes, L. M., Romijn, J. A., Ouwens, D. M., Pijl, H., & Guigas, B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.01.029 · Cited by 80 · see citing works

Atypical antipsychotics and effects of muscarinic, serotonergic, dopaminergic and histaminergic receptor binding on insulin secretion in vivo: An animal model

Hahn, M., Chintoh, A. F., Giacca, A., Xu, L., Lam, L., Mann, S. W., Fletcher, P. J., Guenette, M. D., Cohn, T. A., Wolever, T., et al. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.06.004 · Cited by 76 · see citing works

Parental history of Type 2 diabetes in patients with nonaffective psychosis

Fernández-Egea, E., Miller, B., Bernardo, M., Donner, T. W., & Kirkpatrick, B. W. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.10.002 · Cited by 75 · see citing works

Differential Effects of Various Typical and Atypical Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse: Evidence for the Involvement of Sympathetic Regulation

Savoy, Y. E., Ashton, M. A., Miller, M. W., Nedza, F. M., Spracklin, D. K., Hawthorn, M. H., Rollema, H., Matos, F. F., & Hajós‐Korcsok, É. (2008) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn104 · Cited by 75 · see citing works

Role of the M 3 muscarinic acetylcholine receptor in β‐cell function and glucose homeostasis

Gautam, D., Han, S. J., Duttaroy, A., Mears, D. J., Hamdan, F. F., Li, J. H., Cui, Y., Jeon, J., & Wess, J. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00781.x · Cited by 74 · see citing works

Evaluation of Insulin Sensitivity in Healthy Volunteers Treated with Olanzapine, Risperidone, or Placebo: A Prospective, Randomized Study Using the Two-Step Hyperinsulinemic, Euglycemic Clamp

Sowell, M. O., Mukhopadhyay, N. D., Cavazzoni, P. A., Carlson, C. D., Mudaliar, S. R. D., Chinnapongse, S., Ray, A. J., Davis, T., Breier, A. F., Henry, R. R., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021884 · Cited by 69 · see citing works

The Early Effect of Olanzapine and Risperidone on Insulin Secretion in Atypical-naïve Schizophrenic Patients

Chiu, C.-C., Chen, K.-P., Liu, H.-C., & Lu, M. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000237947.80764.d9 · Cited by 67 · see citing works

Histamine receptor signaling in energy homeostasis

Tabarean, I. V. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.04.011 · Cited by 64 · see citing works

Betahistine ameliorates olanzapine-induced weight gain through modulation of histaminergic, NPY and AMPK pathways

Lian, J., Huang, X., Pai, N. B., & Deng, C. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.06.010 · Cited by 62 · see citing works

Clozapine-Induced Alteration of Glucose Homeostasis in the Rat: The Contribution of Hypothalamic-Pituitary-Adrenal Axis Activation

Tulipano, G., Rizzetti, M. C., Bianchi, I., Fanzani, A., Spano, P., & Cocchi, D. (2007) · Neuroendocrinology · doi:10.1159/000100981 · Cited by 61 · see citing works

Obesity exacerbates the acute metabolic side effects of olanzapine

Townsend, L. K., Peppler, W. T., Bush, N. D., & Wright, D. C. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.12.004 · Cited by 59 · see citing works

Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′‐monophosphate‐activated protein kinase

Ikegami, M., Ikeda, H., Ohashi, T., Ohsawa, M., Ishikawa, Y., Kai, M., Kamei, A., & Kamei, J. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12148 · Cited by 58 · see citing works

Atypical antipsychotics and diabetic ketoacidosis: a review

Guenette, M. D., Hahn, M., Cohn, T. A., Teo, C., & Remington, G. J. (2013) · Psychopharmacology · doi:10.1007/s00213-013-2982-3 · Cited by 55 · see citing works

The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063

Assié, M., Carilla-Durand, E., Bardin, L., Maraval, M., Aliaga, M., Malfetes, N., Barbara, M., & Newman‐Tancredi, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.105 · Cited by 54 · see citing works

Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects

Skrede, S., Martins, L., Berge, R. K., Steen, V. M., López, M., & Fernø, J. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000862 · Cited by 53 · see citing works

Insulin resistance following continuous, chronic olanzapine treatment: An animal model

Chintoh, A. F., Mann, S. W., Lam, T. K. T., Giacca, A., & Remington, G. J. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.06.006 · Cited by 53 · see citing works

Routine exercise ameliorates the metabolic side-effects of treatment with the atypical antipsychotic drug olanzapine in rats

Boyda, H. N., Ramos‐Miguel, A., Procyshyn, R. M., Töpfer, E. T., Lant, N., Choy, H. H.-T., Wong, R., LI, L. C., Pang, C. C. Y., Honer, W. G., et al. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000795 · Cited by 52 · see citing works

Adiposity and Insulin Sensitivity Derived from Intravenous Glucose Tolerance Tests in Antipsychotic-Treated Patients

Haupt, D. W., Fahnestock, P. A., Flavin, K. S., Schweiger, J. A., Stevens, A., HESSLER, M. J., Maeda, J. A., Yingling, M. D., & Newcomer, J. W. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301392 · Cited by 51 · see citing works

Antagonism of the Serotonin (5-HT)-2 Receptor and Insulin Sensitivity: Implications for Atypical Antipsychotics

Gilles, M., Wilke, A., Kopf, D., Nonell, A., Lehnert, H., & Deuschle, M. (2005) · Psychosomatic Medicine · doi:10.1097/01.psy.0000174994.91245.34 · Cited by 50 · see citing works

Interaction Between the Central and Peripheral Effects of Insulin in Controlling Hepatic Glucose Metabolism in the Conscious Dog

Ramnanan, C. J., Kraft, G., Smith, M. S., Farmer, B., Neal, D. W., Williams, P. E., Lautz, M., Farmer, T. E., Donahue, E. P., Cherrington, A. D., et al. (2012) · Diabetes · doi:10.2337/db12-0148 · Cited by 48 · see citing works

Dopaminergic neurotoxin administration to the area of the suprachiasmatic nuclei induces insulin resistance

Luo, S., Luo, J., MEIER, A. H., & Cincotta, A. H. (1997) · Neuroreport · doi:10.1097/00001756-199711100-00016 · Cited by 47 · see citing works

Olanzapine induces glucose intolerance through the activation of AMPK in the mouse hypothalamus

Ikegami, M., Ikeda, H., Ishikawa, Y., Ohsawa, M., Ohashi, T., Kai, M., Kamei, A., & Kamei, J. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.08.006 · Cited by 45 · see citing works

Muscarinic stimulation exerts both stimulatory and inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically excitable pancreatic B-cell

Gilon, P., Nenquin, M., & Henquin, J. C. (1995) · Biochemical Journal · doi:10.1042/bj3110259 · Cited by 44 · see citing works

Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats

Murashita, M. M., Kusumi, I., Hosoda, H., Kangawa, K., & Koyama, T. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.007 · Cited by 42 · see citing works

Glucagon receptor knockout mice are protected against acute olanzapine-induced hyperglycemia

Castellani, L. N., Peppler, W. T., Sutton, C. D., Whitfield, J., Charron, M. J., & Wright, D. C. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.005 · Cited by 41 · see citing works

Acute Peripheral but Not Central Administration of Olanzapine Induces Hyperglycemia Associated with Hepatic and Extra-Hepatic Insulin Resistance

Girault, E. M., Alkemade, A., Foppen, E., Ackermans, M. T., Fliers, E., & Kalsbeek, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043244 · Cited by 39 · see citing works

In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact

Kowalchuk, C., Teo, C., Wilson, V. S., Chintoh, A. F., Lam, L., Agarwal, S. M., Giacca, A., Remington, G. J., & Hahn, M. (2017) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.170092 · Cited by 39 · see citing works

Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatment

Wani, R. A., Dar, M. A., Margoob, M. A., Rather, Y. H., Haq, I., & Shah, M. S. (2014) · Journal of Neurosciences in Rural Practice · doi:10.4103/0976-3147.143182 · Cited by 37 · see citing works

STUDIES ON THE HYPERGLYCAEMIA INDUCED BY CHLORPROMAZINE IN RATS

BONACCORSI, A., Garattini, S. K., & Jori, A. (1964) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1964.tb01570.x · Cited by 36 · see citing works

Atypical antipsychotics and effects of adrenergic and serotonergic receptor binding on insulin secretion in-vivo: An animal model

Guenette, M. D., Giacca, A., Hahn, M., Teo, C., Lam, L., Chintoh, A. F., Arenovich, T., & Remington, G. J. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.02.023 · Cited by 31 · see citing works

A Role for Hypothalamic AMP-Activated Protein Kinase in the Mediation of Hyperphagia and Weight Gain Induced by Chronic Treatment with Olanzapine in Female Rats

SEJIMA, E., Yamauchi, A., Nishioku, T., Koga, M., Nakagama, K., Dohgu, S., Futagami, K., & Kataoka, Y. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9663-8 · Cited by 29 · see citing works

Effects of four atypical antipsychotics on autonomic nervous system activity in schizophrenia

Hattori, S., Kishida, I., Suda, A., Miyauchi, M., Shiraishi, Y., Fujibayashi, M., Tsujita, N., Ishii, C., Ishii, N., Moritani, T., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.004 · Cited by 29 · see citing works

At therapeutic concentrations, olanzapine does not affect basal or insulin-stimulated glucose transport in 3T3-L1 adipocytes

Robinson, K. A., Wasef, S. Z. Y., & Buse, M. G. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.06.008 · Cited by 26 · see citing works

Topiramate in Schizophrenia

Hahn, M., Cohn, T. A., Teo, C., & Remington, G. J. (2013) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.haco.01062013 · Cited by 24 · see citing works

Effects of intracerebroventricular (ICV) olanzapine on insulin sensitivity and secretion in vivo: An animal model

Hahn, M., Chintoh, A. F., Remington, G. J., Teo, C., Mann, S. W., Arenovich, T., Fletcher, P. J., Lam, L., Nóbrega, J. N., Guenette, M. D., et al. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.07.011 · Cited by 22 · see citing works

Mechanism Underlying Induction of Hyperglycemia in Rats by Single Administration of Olanzapine

Nagata, M., Nakajima, M., Ishiwata, Y., Takahashi, Y., Takahashi, H., Negishi, K., & Yasuhara, M. (2016) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00842 · Cited by 22 · see citing works

An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine

Wu, C., Yuen, J. W. Y., Boyda, H. N., Procyshyn, R. M., Wang, C. K., Asiri, Y. I., Pang, C. C. Y., Honer, W. G., & Barr, A. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107116 · Cited by 21 · see citing works

Orally Disintegrating and Oral Standard Olanzapine Tablets Similarly Elevate the Homeostasis Model Assessment of Insulin Resistance Index and Plasma Triglyceride Levels in 12 Healthy Men

Vidarsdóttir, S., Vlug, P., Roelfsema, F., Frölich, M., & Pijl, H. (2010) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04654yel · Cited by 21 · see citing works

More than satiety: central serotonin signaling and glucose homeostasis.

Pissios, P., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.009 · Cited by 20 · see citing works

Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?

Dash, S., Xiao, C., Morgantini, C., Koulajian, K., & Lewis, G. F. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1371 · Cited by 18 · see citing works

Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder

Hardy, T. A., Henry, R. R., FORRESTER, T. D., Kryzhanovskaya, L., Campbell, G. M., Marks, D. M., & Mudaliar, S. R. D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01398.x · Cited by 17 · see citing works

Insulin Secretion and Sensitivity after Single-Dose Amisulpride, Olanzapine or Placebo in Young Male Subjects: Double Blind, Cross-Over Glucose Clamp Study

Kopf, D., Gilles, M., Paslakis, G., Medlin, F., Lederbogen, F., Lehnert, H., & Deuschle, M. (2012) · Pharmacopsychiatry · doi:10.1055/s-0031-1301365 · Cited by 17 · see citing works

A prospective study of glucose homeostasis in quetiapine-treated schizophrenic patients by using the intravenous glucose tolerance test

Chen, C.-H., Lin, T., Chen, T.-T., Chen, V. C., Lin, N.-C., Shao, W., & Lu, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2011.01.015 · Cited by 16 · see citing works

Acute Insulin Response and β-Cell Compensation in Normal Subjects Treated With Olanzapine or Risperidone for 2 Weeks

Hardy, T. A., Meyers, A. L., Yu, J., Shankar, S. S., Steinberg, H. O., & Pørksen, N. K. (2006) · Diabetes Care · doi:10.2337/dc06-1063 · Cited by 16 · see citing works

Glucose Tolerance and Serum Insulin Levels in an Animal Model of Obesity Induced by the Antipsychotic Drug, Sulpiride

Baptista, T., Lacruz, A., & Hernández, L. (1998) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1998.tb01444.x · Cited by 14 · see citing works

Chlorpromazine exacerbates hepatic insulin sensitivity via attenuating insulin and leptin signaling pathway, while exercise partially reverses the adverse effects

Park, S., Hong, S. M., Lee, J. E., & Sung, S. R. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.001 · Cited by 13 · see citing works

Mechanisms of hyperglycemic response to chlorpromazine administered into lateral ventricle in rats—I: Possible role of dopaminergic nervous system

Fujimori, K., & IWAMOTO, T. (1974) · Neuropharmacology · doi:10.1016/0028-3908(74)90074-4 · Cited by 10 · see citing works

Chlorpromazine attenuates pancreatic β-cell function and mass through IRS2 degradation, while exercise partially reverses the attenuation

Park, S., Sm, H., Lee, J., Sung, S., & Kim, S. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881106081529 · Cited by 9 · see citing works

Lessons From Each Drug Trial

Marder, S. R. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.3.375 · Cited by 9 · see citing works

Atypical Antipsychotics and Metabolic Syndrome: From Molecular Mechanisms to Clinical Differences

Carli, M., Kolachalam, S., Longoni, B., Pintaudi, A. M., Baldini, M., Aringhieri, S., Fasciani, I., Annibale, P., Maggio, R., & Scarselli, M. (2021) · Pharmaceuticals · doi:10.3390/ph14030238 · Cited by 252 · see citing works

Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

MacKenzie, N. E., Kowalchuk, C., Agarwal, S. M., Costa-Dookhan, K. A., Caravaggio, F., Gerretsen, P., Chintoh, A. F., Remington, G. J., Taylor, V. H., Müller, D. J., et al. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00622 · Cited by 206 · see citing works

Autonomic nervous system dysfunction in schizophrenia: impact on cognitive and metabolic health

Stogios, N., Gdanski, A., Gerretsen, P., Chintoh, A. F., Graff-Guerrero, A., Rajji, T. K., Remington, G., Hahn, M. K., & Agarwal, S. M. (2021) · npj Schizophrenia · doi:10.1038/s41537-021-00151-6 · Cited by 98 · see citing works

Schizophrenia: a disorder of broken brain bioenergetics

Henkel, N., Wu, X., O'Donovan, S. M., Devine, E. A., Jiron, J. M., Rowland, L. M., Sarnyai, Z., Ramsey, A. J., Wen, Z., Hahn, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01494-x · Cited by 99 · see citing works

The effects of antipsychotic medications on microbiome and weight gain in children and adolescents

Bretler, T., Weisberg, H., Koren, O., & Neuman, H. (2019) · BMC Medicine · doi:10.1186/s12916-019-1346-1 · Cited by 98 · see citing works

New roles for dopamine D2 and D3 receptors in pancreatic beta cell insulin secretion

Farino, Z. J., Morgenstern, T. J., Maffei, A., Quick, M., Solís, A. J. D., Wiriyasermkul, P., Freyberg, R. J., Aslanoglou, D., Sorisio, D. A., Inbar, B., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0344-6 · Cited by 93 · see citing works

Diabesity and mood disorders: Multiple links through the microbiota-gut-brain axis

Farzi, A., Hassan, A. M., Zenz, G., & Holzer, P. D. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.003 · Cited by 77 · see citing works

Antipsychotic-Induced Weight Gain in Severe Mental Illness: Risk Factors and Special Considerations

Stogios, N., Humber, B. E., Agarwal, S. M., & Hahn, M. (2023) · Current Psychiatry Reports · doi:10.1007/s11920-023-01458-0 · Cited by 60 · see citing works

Immunoendocrine Peripheral Effects Induced by Atypical Antipsychotics

Álvarez-Herrera, S., Escamilla-Orozco, R. I., Contreras, O. M., Saracco, R., Flores-Medina, Y., Hurtado‐Alvarado, G., Maldonado-García, J. L., Becerril‐Villanueva, E., Pérez‐Sánchez, G., & Pavón, L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00195 · Cited by 47 · see citing works

Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review

Singh, R., Stogios, N., Smith, E., Lee, J., Maksyutynska, K., Au, E., Wright, D. C., Palma, G. D., Graff‐Guerrero, A., Gerretsen, P., et al. (2022) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253221096525 · Cited by 43 · see citing works

Metformin for early comorbid glucose dysregulation and schizophrenia spectrum disorders: a pilot double-blind randomized clinical trial

Agarwal, S. M., Panda, R., Costa-Dookhan, K. A., MacKenzie, N. E., Treen, Q. C., Caravaggio, F., Hashim, E., Leung, G., Kirpalani, A., Matheson, K., et al. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01338-2 · Cited by 41 · see citing works

Antipsychotics differentially regulate insulin, energy sensing, and inflammation pathways in hypothalamic rat neurons

Kowalchuk, C., Kanagasundaram, P., Belsham, D. D., & Hahn, M. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.01.029 · Cited by 41 · see citing works

Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System

Dinesh, A. A., Islam, J., Khan, J., Turkheimer, F., & Vernon, A. C. (2020) · CNS Drugs · doi:10.1007/s40263-020-00765-x · Cited by 39 · see citing works

Effects of Haloperidol, Risperidone, and Aripiprazole on the Immunometabolic Properties of BV-2 Microglial Cells

Rački, V., Marcelić, M., Štimac, I., Petrić, D., & Kučić, N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094399 · Cited by 38 · see citing works

Insulin Resistance/Diabetes and Schizophrenia: Potential Shared Genetic Factors and Implications for Better Management of Patients with Schizophrenia

Zhuo, C., Zhang, Q., Wang, L., Ma, X., Li, R., Ping, J., Zhu, J., Tian, H., & Jiang, D. (2023) · CNS Drugs · doi:10.1007/s40263-023-01057-w · Cited by 40 · see citing works

Adiposity in schizophrenia: A systematic review and meta‐analysis

Smith, E., Singh, R., Lee, J., Colucci, L., Graff‐Guerrero, A., Remington, G. J., Hahn, M., & Agarwal, S. M. (2021) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13365 · Cited by 32 · see citing works

Peripheral and central regulation of insulin by the intestine and microbiome

Schertzer, J. D., & Lam, T. K. T. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00547.2020 · Cited by 31 · see citing works

Brain insulin action: Implications for the treatment of schizophrenia

Agarwal, S. M., Kowalchuk, C., Castellani, L. N., Costa-Dookhan, K. A., Caravaggio, F., Asgariroozbehani, R., Chintoh, A. F., Graff‐Guerrero, A., & Hahn, M. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.05.032 · Cited by 28 · see citing works

Understanding Mechanisms Underlying Non-Alcoholic Fatty Liver Disease (NAFLD) in Mental Illness: Risperidone and Olanzapine Alter the Hepatic Proteomic Signature in Mice

Rostama, B., Beauchemin, M., Bouchard, C., Bernier, E., Vary, C., May, M. A., & Houseknecht, K. L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249362 · Cited by 27 · see citing works

Metabolic effects of atypical antipsychotics: Molecular targets

Fonseca, M., Carmo, F., & Martel, F. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13347 · Cited by 26 · see citing works

Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches

Shamshoum, H., Medak, K. D., & Wright, D. C. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113049 · Cited by 26 · see citing works

Antipsychotics impair regulation of glucose metabolism by central glucose

Castellani, L. N., Pereira, S., Kowalchuk, C., Asgariroozbehani, R., Singh, R., Wu, S., Hamel, L., Alganem, K., Ryan, W. G., Zhang, X., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01798-y · Cited by 24 · see citing works

Atypical antipsychotics in multiple sclerosis: A review of their in vivo immunomodulatory effects

Stamoula, Ε., Ainatzoglou, A., Stamatellos, V., Dardalas, I., Siafis, S., Matsas, A., Stamoulas, K., & Papazisis, G. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103522 · Cited by 23 · see citing works

Direct effects of antipsychotic drugs on insulin, energy sensing and inflammatory pathways in hypothalamic mouse neurons

Kowalchuk, C., Kanagasundaram, P., McIntyre, W. B., Belsham, D. D., & Hahn, M. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104400 · Cited by 23 · see citing works

Female mice are protected against acute olanzapine-induced hyperglycemia

Medak, K. D., Townsend, L. K., Hahn, M., & Wright, D. C. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104413 · Cited by 22 · see citing works

Antipsychotic-Induced Alterations in Lipid Turnover

Pereira, S., Au, E., Agarwal, S. M., Wright, D. C., & Hahn, M. (2023) · Endocrinology · doi:10.1210/endocr/bqad025 · Cited by 22 · see citing works

Differential Effects of Acute Treatment With Antipsychotic Drugs on Peripheral Catecholamines

Boyda, H. N., Ho, A. A., Tse, L., Procyshyn, R. M., Yuen, J. W. Y., Kim, D. D., Honer, W. G., & Barr, A. M. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.617428 · Cited by 22 · see citing works

Exploring the role of ketone bodies in the diagnosis and treatment of psychiatric disorders

Omori, N. E., Malys, M. K., Woo, G. H., & Mansor, L. S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1142682 · Cited by 18 · see citing works

Weight and metabolic changes in early psychosis―association with daily quantification of medication exposure during the first hospitalization

Vochosková, K., McWhinney, S. R., Fialová, M., Kolenič, M., Španiel, F., Švancer, P., Boron, P., Okaji, Y., Trančík, P., & Hájek, T. (2023) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13594 · Cited by 17 · see citing works

The Candidate Schizophrenia Risk Gene Tmem108 Regulates Glucose Metabolism Homeostasis

Yu, J., Liao, X., Zhong, Y., Wu, Y., Lai, X., Jiao, H., Yan, M., Zhang, Y., Ma, C., & Wang, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.770145 · Cited by 17 · see citing works

Dopamine in the nucleus accumbens shell controls systemic glucose metabolism via the lateral hypothalamus and hepatic vagal innervation in rodents

Diepenbroek, C., Rijnsburger, M., van Irsen, A. A. S., Eggels, L., Kisner, A., Foppen, E., Unmehopa, U. A., Berland, C., Dólleman, S., Hardonk, M. H., et al. (2023) · Metabolism · doi:10.1016/j.metabol.2023.155696 · Cited by 17 · see citing works

On psychology and psychiatry in diabetes

Sridhar, G. R. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_188_20 · Cited by 14 · see citing works

Glucose dysregulation in antipsychotic-naive first-episode psychosis: in silico exploration of gene expression signatures

Lee, J., Xue, X., Au, E., McIntyre, W. B., Asgariroozbehani, R., Panganiban, K. J., Tseng, G. C., Papoulias, M., Smith, E., Monteiro, J., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-023-02716-8 · Cited by 13 · see citing works

Fasting or the short‐term consumption of a ketogenic diet protects against antipsychotic‐induced hyperglycaemia in mice

Shamshoum, H., Medak, K. D., McKie, G. L., Hahn, M., & Wright, D. C. (2022) · The Journal of Physiology · doi:10.1113/jp282922 · Cited by 13 · see citing works

Serum Metabolic Profile in Schizophrenia Patients With Antipsychotic-Induced Constipation and Its relationship With Gut Microbiome

Amdanee, N., Shao, M., Hu, X., Fang, X., Zhou, C., Chen, J., Chattun, M. R., Wen, L., Pan, X., Zhang, X., et al. (2023) · Schizophrenia Bulletin · doi:10.1093/schbul/sbac202 · Cited by 11 · see citing works

SNAP25 mutation disrupts metabolic homeostasis, steroid hormone production and central neurobehavior

Xiao, H., Zhu, B. D., Yang, P., Dong, D., Sahbaie, P., Oliver, P. L., Shen, W., Azhar, S., & Kraemer, F. B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166304 · Cited by 11 · see citing works

Effects of acute olanzapine exposure on central insulin-mediated regulation of whole body fuel selection and feeding

Castellani, L. N., Wilkin, J., Abela, A. R., Benarroch, L., Ahasan, Z., Teo, C., Wilson, V. S., Kowalchuk, C., Giacca, A., Remington, G. J., et al. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.028 · Cited by 11 · see citing works

Risk factors for abnormal glucose metabolism during antipsychotic treatment: A prospective cohort study

Miyakoshi, T., Ishikawa, S., Okubo, R., Hashimoto, N., Sato, N., Kusumi, I., & Ito, Y. M. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.10.055 · Cited by 10 · see citing works

Olanzapine-induced insulin resistance may occur via attenuation of central KATP channel-activation

Kowalchuk, C., Castellani, L. N., Kanagsundaram, P., McIntyre, W. B., Asgariroozbehani, R., Giacca, A., & Hahn, M. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2020.12.005 · Cited by 10 · see citing works

The type rather than the daily dose or number of antipsychotics affects the incidence of hyperglycemic progression

Ishikawa, S., Yamamura, R., Hashimoto, N., Okubo, R., Sawagashira, R., Ito, Y. M., Sato, N., & Kusumi, I. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110453 · Cited by 10 · see citing works

Olanzapine Induces Adipogenesis and Glucose Uptake by Activating Glycolysis and Synergizing with the PI3K-AKT Pathway

Li, S., Fu, Y., Wang, W., Qiu, J., Huang, Y., Li, X., Yang, K., Yu, X., Ma, Y., Zhang, Y., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666240815120547 · Cited by 9 · see citing works

Attenuation of Olanzapine-Induced Endoplasmic Reticulum Stress Improves Insulin Secretion in Pancreatic Beta Cells

Grajales, D., Vázquez, P., Alén, R., Hitos, A. B., & Valverde, Á. M. (2022) · Metabolites · doi:10.3390/metabo12050443 · Cited by 9 · see citing works

Graph theory analysis of a human body metabolic network: A systematic and organ‐specific study

Ruan, J., Wu, Y., Wang, H., Huang, Z., Liu, Z., Yang, X., Yang, Y., Zheng, H., Liang, D., Wang, M., et al. (2024) · Medical Physics · doi:10.1002/mp.17568 · Cited by 8 · see citing works

Voluntary physical activity protects against olanzapine-induced hyperglycemia

Shamshoum, H., McKie, G. L., Medak, K. D., Ashworth, K. E., Kemp, B. E., & Wright, D. C. (2020) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00876.2020 · Cited by 8 · see citing works

GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice

Peng, Y., Feng, C., Peng, S., Wang, Y., Zhang, Q., Jiao, Z., Cao, H., Huang, S., Tian, P., Sun, X., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01252-7 · Cited by 7 · see citing works

Development of Novel Tools for Dissection of Central Versus Peripheral Dopamine D2-Like Receptor Signaling in Dysglycemia

Bonifazi, A., Ellenberger, M. P., Farino, Z. J., Aslanoglou, D., Rais, R., Pereira, S., Mantilla-Rivas, J. O., Boateng, C. A., Eshleman, A. J., Janowsky, A. J., et al. (2024) · Diabetes · doi:10.2337/db24-0175 · Cited by 7 · see citing works

Antipsychotic Drug-Induced Increases in Peripheral Catecholamines are Associated With Glucose Intolerance

Boyda, H. N., Pham, M. M., Huang, J. Y., Ho, A. A., Procyshyn, R. M., Yuen, J. W. Y., Honer, W. G., & Barr, A. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.765905 · Cited by 7 · see citing works

Thermoneutral housing and preexisting obesity do not abolish the sexually dimorphic effects of olanzapine on weight gain in mice

Seguin, I., Medak, K. D., Shamshoum, H., Hahn, M., & Wright, D. C. (2023) · Obesity · doi:10.1002/oby.23630 · Cited by 7 · see citing works

Electroconvulsive therapy and adiposity-related parameters in treatment-resistant depressed patients

Maier, H. B., Pollak, C., Moschny, N., Toto, S., Schlatt, C., Eberlein, C. K., Sperling, W., Kornhuber, J., Kahl, K. G., Bleich, S., et al. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02475-8 · Cited by 6 · see citing works

Olanzapine’s effects on hypothalamic transcriptomics and kinase activity

Pereira, S., Castellani, L. N., Kowalchuk, C., Alganem, K., Zhang, X., Ryan, W. G., Singh, R., Wu, S., Au, E., Asgariroozbehani, R., et al. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.106987 · Cited by 6 · see citing works

Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model

Horská, K., Skrede, S., Kucera, J., Kuzmínová, G., Suchý, P., Micale, V., & Kučerová, J. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14565 · Cited by 6 · see citing works

Investigating the effects of antipsychotics on brain insulin action: Study protocol for a multi-modality magnetic resonance imaging (MRI) study in healthy controls

Stogios, N., Hamel, L., Smith, E., Sanches, M., Remington, G. J., Voineskos, A. N., Dash, S., Graff‐Guerrero, A., Hahn, M., & Agarwal, S. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0277211 · Cited by 5 · see citing works

Enhancing endogenous levels of GLP1 dampens acute olanzapine induced perturbations in lipid and glucose metabolism

Medak, K. D., Weber, A. J., Shamshoum, H., McKie, G. L., Hahn, M., & Wright, D. C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1127634 · Cited by 5 · see citing works

Dopamine-mediated autocrine inhibition of insulin secretion

Ferrero, E., Masini, M., Carli, M., Moscato, S., Beffy, P., Vaglini, F., Mattii, L., Corti, A., Scarselli, M., Novelli, M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112294 · Cited by 4 · see citing works

Circulating IGFBP-2 levels reveal atherogenic metabolic risk in schizophrenic patients using atypical antipsychotics

Nolin, M.-A., Demers, M., Rauzier, C., Bouchard, R., Cadrin, C., Despres, J., Roy, M., Alméras, N., & Picard, F. (2020) · World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1770858 · Cited by 4 · see citing works

Integrative Management of Metabolic Syndrome in Youth Prescribed Second-Generation Antipsychotics

Rice, J. N., & Ramtekkar, U. P. (2020) · Medical Sciences · doi:10.3390/medsci8030034 · Cited by 5 · see citing works

Sex differences in the prevalence and clinical correlates of diabetes in Chinese patients with chronic schizophrenia

Yan, H., Li, Y., Li, S., Zhou, C., Wei, S., Li, J., & Zhang, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14183 · Cited by 4 · see citing works

Methods for estimating insulin resistance from untargeted metabolomics data

Hsu, F., Palmer, N. D., Chen, S., Ng, M. C. Y., Goodarzi, M. O., Rotter, J. I., Wagenknecht, L. E., Bancks, M. P., Bergman, R. N., & Bowden, D. W. (2023) · Metabolomics · doi:10.1007/s11306-023-02035-5 · Cited by 4 · see citing works

Clinical improvement in schizophrenia during antipsychotic treatment in relation to changes in glucose parameters: A systematic review

Smith, E. C. C., Au, E., Pereira, S., Sharma, E., Venkatasubramanian, G., Remington, G. J., Agarwal, S. M., & Hahn, M. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115472 · Cited by 4 · see citing works

Glucose dysregulation signals in weight-neutral atypical antipsychotics: A pharmacovigilance–pharmacodynamic evaluation of FAERS data

Zheng, L., Xiong, Y., Nie, W., & Si, T. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.120462 · Cited by 3 · see citing works

First exposure to second-generation antipsychotics alters gut microbiota and metabolic profiles in patients with glucose-lipid metabolism disorders

Wu, Y., Zang, S., Wu, Z., & Huang, J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1722760 · Cited by 3 · see citing works

Pharmacological Interventions for Weight Reduction in Patients With Schizophrenia Treated With Antipsychotics

Stogios, N., Agarwal, S. M., Maksyutynska, K., Faisal, H., Pless, L., Pillinger, T., Humber, B. E., Taylor, V. H., Remington, G. J., Faulkner, G., et al. (2026) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2026.1814 · Cited by 3 · see citing works

Antipsychotic Drug Prescription in Pediatric Intensive Care Units: A 10-Year U.S. Retrospective Database Study

Madden, K., Wolf, M., Tasker, R. C., Figueroa, J., McCracken, C., Hall, M., & Kamat, P. (2021) · Journal of Pediatric Intensive Care · doi:10.1055/s-0041-1736523 · Cited by 3 · see citing works

Amylin receptor agonism enhances the effects of liraglutide in protecting against the acute metabolic side effects of olanzapine

Medak, K. D., Jeromson, S., Bellucci, A., Arbeau, M., & Wright, D. C. (2023) · iScience · doi:10.1016/j.isci.2023.108628 · Cited by 3 · see citing works

Neuroreceptor Inhibition by Clozapine Triggers Mitohormesis and Metabolic Reprogramming in Human Blood Cells

Fehsel, K., Bouvier, M.-L., Capobianco, L., Lunetti, P., Klein, B., Oldiges, M., Majora, M., & Löffler, S. (2024) · Cells · doi:10.3390/cells13090762 · Cited by 3 · see citing works

Antipsychotic-Induced Dysregulation of Glucose Metabolism Through the Central Nervous System: A Scoping Review of Animal Models

Au, E., Panganiban, K. J., Wu, S., Sun, K., Humber, B. E., Remington, G. J., Agarwal, S. M., Giacca, A., Pereira, S., & Hahn, M. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.10.001 · Cited by 3 · see citing works

Atypical Antipsychotic Medications Disrupt the Cardio-Metabolic and Cardio-Immune Axes

Rostama, B., May, M. A., & Houseknecht, K. (2020) · Interventional Cardiology · doi:10.37532/fmic.2020.12(2).648 · Cited by 3 · see citing works

Cardiovascular protein profiling in patients with first-episode psychosis

Malmqvist, A., Eren, F., Schwieler, L., Orhan, F., Fatouros‐Bergman, H., Flyckt, L., Piehl, F., Červenka, S., Bäck, M., Sellgren, C. M., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00633-x · Cited by 2 · see citing works

Comparative study of eating behavior between patients with mental illness and healthy controls using the Japanese version of the Dutch Eating Behavior Questionnaire.

Okabe, S., Ito, S., Goto, A., & Konno, N. (2024) · PubMed Central · doi:10.6133/apjcn.202406_33(2).0009 · Cited by 2 · see citing works

Depolarization of coherent backscattering

Kuzmin, V. L., Romanov, V. P., & Kuzmin, L. V. (1992) · Optics and Spectroscopy · Cited by 2 · see citing works

The fecal microbiota transplantation from drug-naïve schizophrenia patients distinctively changes gut microbiome and metabolic profiles in male and female micePreprint

Singh, R., Pereira, S., Panganiban, K. J., Hamel, L., Wright, D. C., Prevot, T. D., Müller, D. J., Remington, G. J., Agarwal, S. M., Berčík, P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.13.675957 · Cited by 2 · see citing works

GLP-2 attenuates antipsychotics’ adverse metabolic effects

Pereira, S., & Hahn, M. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01248-3 · Cited by 1 · see citing works

Interaction between the brain and multiple organ systems in schizophrenia

Lin, J. S., Feng, S., Wu, Z.-Y., Dong, L., Yin, D., Hong, Z., Jia, H., & Ning, Y. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i8.107696 · Cited by 1 · see citing works

Rapid formation of cataract after starting ziprasidone with spontaneous regression after therapy was discontinued

Chou, T. Y., Bricel, S., & Yazdanie, M. (2019) · Journal of Cataract and Refractive Surgery Online Case Reports · doi:10.1016/j.jcro.2019.04.002 · Cited by 1 · see citing works

Challenges in the management of gestational diabetes mellitus in anorexia nervosa

Siddiqui, R., & McAdams, C. J. (2024) · Psychiatry Research Case Reports · doi:10.1016/j.psycr.2024.100215 · Cited by 1 · see citing works

Glia-related Acute Effects of Risperidone and Haloperidol in Hippocampal Slices and Astrocyte Cultures from Adult Wistar Rats: A Focus on Inflammatory and Trophic Factor Release

da Silva, A., Bobermin, L. D., Santos, C. L., Almeida, R. R. D. S., Lissner, L. J., dos Santos, T. M., Seady, M., Leite, M. C., Wyse, Â. T. D. S., Gonçalves, C., et al. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04273-y · Cited by 2 · see citing works

Investigating the Gut Microbiome, Metabolomic Signatures, and Metabolic Dysfunction in Antipsychotic Naïve Patients

Costa-Dookhan, K. A. (2020) · TSpace (University of Toronto)

DETERMINATION OF THE PREVALENCE AND CLINICAL OUTCOME OF STRESS-INDUCED HYPERGLYCEMIA IN ICU OF IMAM KHOMEINI HOSPITAL, URMIA

Hatamkhani, S., Tajeri, A., Shiva, A., Hasanloei, M. A. V., & Sharifi, H. (2021) · Studies in Medical Sciences · doi:10.52547/umj.32.7.548

Protective effects of central leptin on whole-body energy homeostasis upon acute olanzapine exposurePreprint

Asgariroozbehani, R., Singh, R., Wu, S., Imami, A. S., Hamoud, A.-R. A., Agarwal, S. M., Baranowski, B. J., Jeromson, S., Bernardo, A. M., Prévot, T. D., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.11.648424

Linking Brain, Hormones, and Metabolism: Pathophysiology and Treatment of Antipsychotic-Induced Cardiometabolic Side Effects

Milano, W., Campanile, R., Marchese, M., Milano, M. F., Ragozino, L., Saetta, B., & Capasso, A. (2026) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2602330

From brain bioenergetics to hypothalamic glucoregulation: A shared-systems hypothesis for intrinsic dysglycemia in schizophrenia

Hamel, L., Pereira, S. X. E. R. L., Yang, Z., Garrido, A. N., Agarwal, S. M., Lam, T. K. T., & Hahn, M. K. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10034-9 · Cited by 1 · see citing works

Potential adverse effects of antipsychotics during pregnancy: A narrative review with a focus on metabolic alterations

Ramírez‐Herrera, O., D’Espessailles, A., Burrone, M. S., & Santander, N. G. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118266

GLP-1 Receptor Agonist and GIP/GLP-1 Receptor Dual Agonist Therapeutics at the Intersection of Alcohol Use Disorder, Obesity, and Cardiometabolic Dysfunction

Reitz, J., Rosoff, D. B., Pacher, P., & Lohoff, F. W. (2026) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2026.100793

Protective effects of central leptin on whole-body energy homeostasis following acute olanzapine exposure

Singh, R., Asgariroozbehani, R., Wu, S., Imami, A. S., Hamoud, A.-R. A., Baranowski, B. J., Jeromson, S., Bernardo, A. M., Prévot, T. D., Agarwal, S. M., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111180

Effects of Antipsychotics on Skeletal Muscle Molecular Pathways: A Systematic Review

Burghardt, K. J., Jaiswal, R., Zeineddine, M., & Yi, Z. (2026) · Life · doi:10.3390/life16111826

P03-152 - Atypical Antipsychotics: Causing Craziness in Glucose Regulation?

Xiu, P. Y., Patil, A. D., Agius, M. A., & Zaman, R. (2010) · European Psychiatry · doi:10.1016/s0924-9338(10)71122-6

Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.

Newcomer, J. W. (2004) · PubMed · Cited by 109 · see citing works

Metabolic Consequences of Antipsychotic Therapy: Preclinical and Clinical Perspectives on Diabetes, Diabetic Ketoacidosis, and Obesity

Heal, D. J., Gosden, J., Jackson, H. C., Cheetham, S. C., & Smith, S. L. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_6 · Cited by 26 · see citing works

The Metabolic Syndrome During Atypical Antipsychotic Drug Treatment: Mechanisms and Management

Baptista, T., Mendoza, S., Beaulieu, S., Bermúdez, A., & Martinez, M. (2004) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2004.2.290 · Cited by 42 · see citing works

The Diabetogenic Effects of Antipsychotic Medications: From Rodents to Humans

Hahn, M. (2013) · TSpace (University of Toronto)